Corcept Therapeutics Incorporated (CORT)
NASDAQ: CORT · Real-Time Price · USD
122.34
+3.80 (3.21%)
Oct 9, 2026, 2:26 PM EDT - Market open
Corcept Therapeutics Employees
Corcept Therapeutics had 730 employees as of December 31, 2025. The number of employees increased by 230 or 46.00% compared to the previous year. That makes Corcept Therapeutics the 17,204th largest employer in the world and 2,394th in the United States.
Employees
730
Change (1Y)
230
Growth (1Y)
46.00%
Revenue / Employee
$1,138,100
Profits / Employee
$74,342
Market Cap
13.22B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 730 | 230 | 46.00% | 730 | 0 |
| Dec 31, 2024 | 500 | 148 | 42.05% | 500 | 0 |
| Dec 31, 2023 | 352 | 53 | 17.73% | 352 | 0 |
| Dec 31, 2022 | 299 | 61 | 25.63% | 299 | 0 |
| Dec 31, 2021 | 238 | 2 | 0.85% | 238 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| BioMarin Pharmaceutical | 3,221 |
| Bio-Techne | 3,000 |
| Jazz Pharmaceuticals | 2,890 |
| Ascendis Pharma | 1,189 |
| Exelixis | 1,077 |
| BridgeBio Pharma | 1,003 |
| Twist Bioscience | 979 |
| Madrigal Pharmaceuticals | 915 |
CORT News
- 16 days ago - Corcept Therapeutics president of endocrinology Sean Maduck to retire - TheFly
- 16 days ago - Corcept Announces Planned Leadership Transition - Business Wire
- 21 days ago - Corcept announces positive CHMP opinion for Lifyorli - TheFly
- 21 days ago - Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant) - Business Wire
- 23 days ago - Corcept Grows to Mid-Cap on Institutional Support - FXEmpire
- 7 weeks ago - Corcept Therapeutics assumed with a Buy at Truist - TheFly
- 2 months ago - Raised Guidance Lifts Corcept to 52-Week High - FXEmpire
- 2 months ago - Corcept Therapeutics price target raised to $161 from $150 at Canaccord - TheFly